| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Arcellx, Inc. | 10%+ Owner | Common Stock | 1,658,780 | $91,677,287 | $55.27 | 11 May 2023 | Indirect |
| Zenas BioPharma, Inc. | 10%+ Owner | Common Stock | 1,917,895 | $36,440,005 | $19.00 | 09 Oct 2025 | Indirect |
| eFFECTOR Therapeutics, Inc. | 10%+ Owner | Common Stock | 1,821,415 | $1,104,688 | $0.6065 | 27 Nov 2023 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ZBIO | Zenas BioPharma, Inc. | 09 Oct 2025 | 2 | +$2,399,985 | 4 | 10%+ Owner | 14 Oct 2025, 17:14 |
| ZBIO | Zenas BioPharma, Inc. | 16 Sep 2024 | 9 | +$37,999,998 | 4 | 10%+ Owner | 16 Sep 2024, 20:51 |
| ZBIO | Zenas BioPharma, Inc. | 12 Sep 2024 | 0 | $0 | 3 | 10%+ Owner | 12 Sep 2024, 21:39 |
| /report/000120919123056920-sr-one-capital-management-llc-2023-11-27 | eFFECTOR Therapeutics, Inc. | 27 Nov 2023 | 2 | -$369,457 | 4 | 10%+ Owner | 29 Nov 2023, 17:07 |
| ACLX | Arcellx, Inc. | 11 May 2023 | 4 | -$45,589,317 | 4 | 10%+ Owner | 15 May 2023, 18:16 |
| ACLX | Arcellx, Inc. | 08 Feb 2022 | 12 | +$25,000,005 | 4 | 10%+ Owner | 10 Feb 2022, 07:41 |
| ACLX | Arcellx, Inc. | 03 Feb 2022 | 0 | $0 | 3 | 10%+ Owner | 03 Feb 2022, 17:22 |
| /report/000120919121054402-sr-one-capital-management-llc-2021-08-25 | eFFECTOR Therapeutics, Inc. | 25 Aug 2021 | 0 | $0 | 3 | 10%+ Owner | 02 Sep 2021, 15:26 |